Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial
Transferrin receptors
The findings suggested that ginger has the potential to be a source of lead molecules for development into a therapeutic agent to treat multiple sclerosis
Unfortunately [they were] enrolling heterogeneous patient groups
Hendler SS, Rorvik DR, eds
This ensures that any potential side effects are managed promptly and that dietary and exercise plans are effectively contributing to weight loss and health goals (Premium Health)
US$ 27.36
US$ 21.90
US$ 28.56
US$ 24.88
US$ 22.12
US$ 23.54
US$ 23.31
US$ 25.16
